BACKGROUND AND PURPOSE: Pathologic studies suggest that neovascularization and hemorrhage are important features of plaque vulnerability for disruption. Our aim was to determine the associations of these features in carotid plaques with previous cerebrovascular ischemic events by using high-resolution CE-MRI. MATERIALS AND METHODS: Forty-seven patients (36 men; mean age 72.5 ± 10 years) underwent CE-MRI and MRA examinations for carotid plaque at 3T. IPH presence was recorded. Neovascularity was categorized by the degree of adventitial enhancement (0, absent; 1, <50%; 2, ≥50%). Reader variability was assessed by using weighted κ. Associations with events were determined by using multivariable logistic regression. RESULTS: Intra- and inter-reader agreement for grading adventitial enhancement were good to excellent. IPH was present in 49% of patients and was associated with events (P = .03). Patients grouped by categories 0, 1, and 2 adventitial enhancement had increasing frequencies of events (14% category 0, 48% category 1, 65% category 2; P = .02). Events were associated with IPH (OR, 10.18; 95% CI, 1.42-72.21) and adventitial enhancement (compared with category 0: OR, 14.90, 95% CI, 0.98-225.93 for category 1; OR, 51.17, 95% CI, 3.4-469.8 for category 2) after controlling for age, sex, cardiovascular risk factors, wall thickness, and stenosis. Stenosis was not associated with events. CONCLUSIONS: Adventitial enhancement and IPH are independently associated with previous events and may provide important insight into stroke risk not achievable by stenosis.
BACKGROUND AND PURPOSE: Pathologic studies suggest that neovascularization and hemorrhage are important features of plaque vulnerability for disruption. Our aim was to determine the associations of these features in carotid plaques with previous cerebrovascular ischemic events by using high-resolution CE-MRI. MATERIALS AND METHODS: Forty-seven patients (36 men; mean age 72.5 ± 10 years) underwent CE-MRI and MRA examinations for carotid plaque at 3T. IPH presence was recorded. Neovascularity was categorized by the degree of adventitial enhancement (0, absent; 1, <50%; 2, ≥50%). Reader variability was assessed by using weighted κ. Associations with events were determined by using multivariable logistic regression. RESULTS: Intra- and inter-reader agreement for grading adventitial enhancement were good to excellent. IPH was present in 49% of patients and was associated with events (P = .03). Patients grouped by categories 0, 1, and 2 adventitial enhancement had increasing frequencies of events (14% category 0, 48% category 1, 65% category 2; P = .02). Events were associated with IPH (OR, 10.18; 95% CI, 1.42-72.21) and adventitial enhancement (compared with category 0: OR, 14.90, 95% CI, 0.98-225.93 for category 1; OR, 51.17, 95% CI, 3.4-469.8 for category 2) after controlling for age, sex, cardiovascular risk factors, wall thickness, and stenosis. Stenosis was not associated with events. CONCLUSIONS: Adventitial enhancement and IPH are independently associated with previous events and may provide important insight into stroke risk not achievable by stenosis.
Authors: Jianming Cai; Thomas S Hatsukami; Marina S Ferguson; William S Kerwin; Tobias Saam; Baocheng Chu; Norihide Takaya; Nayak L Polissar; Chun Yuan Journal: Circulation Date: 2005-11-21 Impact factor: 29.690
Authors: M J McCarthy; I M Loftus; M M Thompson; L Jones; N J London; P R Bell; A R Naylor; N P Brindle Journal: J Vasc Surg Date: 1999-08 Impact factor: 4.268
Authors: Jose Luis Martín-Ventura; Luis Miguel Blanco-Colio; Almudena Gómez-Hernández; Begoña Muñoz-García; Melina Vega; Javier Serrano; Luis Ortega; Gonzalo Hernández; José Tuñón; Jesús Egido Journal: Stroke Date: 2005-07-14 Impact factor: 7.914
Authors: Tobias Saam; Jianming Cai; Lin Ma; You-Quan Cai; Marina S Ferguson; Nayak L Polissar; Thomas S Hatsukami; Chun Yuan Journal: Radiology Date: 2006-08 Impact factor: 11.105
Authors: Renu Virmani; Frank D Kolodgie; Allen P Burke; Aloke V Finn; Herman K Gold; Thomas N Tulenko; Steven P Wrenn; Jagat Narula Journal: Arterioscler Thromb Vasc Biol Date: 2005-07-21 Impact factor: 8.311
Authors: Matthew D Alexander; Adam de Havenon; Seong-Eun Kim; Dennis L Parker; Joseph S McNally Journal: Neuroradiology Date: 2019-01-24 Impact factor: 2.804
Authors: D M Mandell; M Mossa-Basha; Y Qiao; C P Hess; F Hui; C Matouk; M H Johnson; M J A P Daemen; A Vossough; M Edjlali; D Saloner; S A Ansari; B A Wasserman; D J Mikulis Journal: AJNR Am J Neuroradiol Date: 2016-07-28 Impact factor: 3.825
Authors: A Gupta; H Baradaran; H Kamel; A Mangla; A Pandya; V Fodera; A Dunning; P C Sanelli Journal: AJNR Am J Neuroradiol Date: 2013-09-05 Impact factor: 3.825
Authors: Jie Sun; Yan Song; Huijun Chen; William S Kerwin; Daniel S Hippe; Li Dong; Min Chen; Cheng Zhou; Thomas S Hatsukami; Chun Yuan Journal: Stroke Date: 2013-03-07 Impact factor: 7.914
Authors: Ye Qiao; Steven R Zeiler; Saeedeh Mirbagheri; Richard Leigh; Victor Urrutia; Robert Wityk; Bruce A Wasserman Journal: Radiology Date: 2014-01-16 Impact factor: 11.105